BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38778014)

  • 1. Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.
    Wang J; Yu Y; Tan Y; Wan H; Zheng N; He Z; Mao L; Ren W; Chen K; Lin Z; He G; Chen Y; Chen R; Xu H; Liu K; Yao Q; Fu S; Song Y; Chen Q; Zuo L; Wei L; Wang J; Ouyang N; Yao H
    Nat Commun; 2024 May; 15(1):4369. PubMed ID: 38778014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
    Bao H; Bi H; Zhang X; Zhao Y; Dong Y; Luo X; Zhou D; You Z; Wu Y; Liu Z; Zhang Y; Liu J; Fang L; Wang L
    Gynecol Oncol; 2020 Oct; 159(1):171-178. PubMed ID: 32814641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.
    Bao H; Sun X; Zhang Y; Pang B; Li H; Zhou L; Wu F; Cao D; Wang J; Turic B; Wang L
    Cancer Med; 2020 Sep; 9(18):6896-6906. PubMed ID: 32697872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep learning based cervical screening by the cross-modal integration of colposcopy, cytology, and HPV test.
    Fu L; Xia W; Shi W; Cao GX; Ruan YT; Zhao XY; Liu M; Niu SM; Li F; Gao X
    Int J Med Inform; 2022 Mar; 159():104675. PubMed ID: 34979436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the Accuracy and Efficiency of Abnormal Cervical Squamous Cell Detection With Cytologist-in-the-Loop Artificial Intelligence.
    Xue P; Xu HM; Tang HP; Weng HY; Wei HM; Wang Z; Zhang HY; Weng Y; Xu L; Li HX; Seery S; Han X; Ye H; Qiao YL; Jiang Y
    Mod Pathol; 2023 Aug; 36(8):100186. PubMed ID: 37059230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting.
    Holmström O; Linder N; Kaingu H; Mbuuko N; Mbete J; Kinyua F; Törnquist S; Muinde M; Krogerus L; Lundin M; Diwan V; Lundin J
    JAMA Netw Open; 2021 Mar; 4(3):e211740. PubMed ID: 33729503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
    Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
    BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence-driven Digital Cytology-based Cervical Cancer Screening: Is the Time Ripe to Adopt This Disruptive Technology in Resource-constrained Settings? A Literature Review.
    Gupta R; Kumar N; Bansal S; Singh S; Sood N; Gupta S
    J Digit Imaging; 2023 Aug; 36(4):1643-1652. PubMed ID: 37029285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology.
    Lee M; Chang MY; Shin HY; Shin E; Hong SW; Kim KM; Chay DB; Cho H; Kim JH
    Medicine (Baltimore); 2016 Jan; 95(3):e2425. PubMed ID: 26817873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary HPV testing with cytology versus cytology alone in cervical screening-A prospective randomized controlled trial with two rounds of screening in a Chinese population.
    Chan KKL; Liu SS; Wei N; Ngu SF; Chu MMY; Tse KY; Lau LSK; Cheung ANY; Ngan HYS
    Int J Cancer; 2020 Aug; 147(4):1152-1162. PubMed ID: 31922265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of artificial intelligence-assisted diagnosis for cervical liquid-based thin-layer cytology].
    Zhu XH; Li XM; Zhang WL; Liao MM; Li Y; Wang FF; Shang B; Peng LG; Su YJ; You ZJ; Shi JY; Zhong WL; Liang XR; Liang CJ; Liang L; Liao WT; Ding YQ
    Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):333-338. PubMed ID: 33831990
    [No Abstract]   [Full Text] [Related]  

  • 13. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age.
    Pierry D; Weiss G; Lack B; Chen V; Fusco J
    Arch Pathol Lab Med; 2012 Aug; 136(8):956-60. PubMed ID: 22849745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.
    Baleydier I; Vassilakos P; Viñals R; Wisniak A; Kenfack B; Tsuala Fouogue J; Enownchong Enow Orock G; Lemoupa Makajio S; Foguem Tincho E; Undurraga M; Cattin M; Makohliso S; Schönenberger K; Gervaix A; Thiran JP; Petignat P
    PLoS One; 2021; 16(12):e0260776. PubMed ID: 34914727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating cytology for the detection of invasive cervical cancer.
    Landy R; Castanon A; Hamilton W; Lim AW; Dudding N; Hollingworth A; Sasieni PD
    Cytopathology; 2016 Jun; 27(3):201-9. PubMed ID: 26126636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
    Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
    Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of Combined Liquid Based Cervical Cytology and High-Risk HPV mRNA for Cervical Cancer Screening in Thammasat University Hospital.
    Muangto T; Chanthasenanont A; Lertvutivivat S; Nanthakomon T; Pongrojpaw D; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2016; 17(9):4409-4413. PubMed ID: 27797253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
    Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
    Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.